<code id='51B89A457E'></code><style id='51B89A457E'></style>
    • <acronym id='51B89A457E'></acronym>
      <center id='51B89A457E'><center id='51B89A457E'><tfoot id='51B89A457E'></tfoot></center><abbr id='51B89A457E'><dir id='51B89A457E'><tfoot id='51B89A457E'></tfoot><noframes id='51B89A457E'>

    • <optgroup id='51B89A457E'><strike id='51B89A457E'><sup id='51B89A457E'></sup></strike><code id='51B89A457E'></code></optgroup>
        1. <b id='51B89A457E'><label id='51B89A457E'><select id='51B89A457E'><dt id='51B89A457E'><span id='51B89A457E'></span></dt></select></label></b><u id='51B89A457E'></u>
          <i id='51B89A457E'><strike id='51B89A457E'><tt id='51B89A457E'><pre id='51B89A457E'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:97642
          Two researchers look at a computer monitor showing a graph and other data
          Adobe

          Research universities are voicing concerns over some proposed changes to the process for reviewing scientific misconduct allegations, citing worries that new government requirements would hobble their own independent procedures and constitute a huge administrative burden.

          Nearly two decades since it last released research misconduct rules, the U.S. Office of Research Integrity (ORI) is ready to update its requirements for ensuring the scientific standards of projects funded by the U.S. Department of Health and Human Services, including the National Institutes of Health.

          advertisement

          The proposed changes, published on Oct. 6, include a new formal process that institutions would follow in reviewing allegations, a 30-day deadline for institutions to assess allegations, and provisions that make it harder to quickly dismiss cases that institutions believe to be “honest errors.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          For Cytokinetics, FDA rejection of heart drug would help, not hinder
          For Cytokinetics, FDA rejection of heart drug would help, not hinder

          MollyFerguson/STATCytokineticswasfounded26yearsagobuthasnotyetdevelopedadrugsuccessfullytoapproval.T

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          When waiting feels immoral: Empathy in the emergency department

          AdobeMr.Kaneisusingonehandtoclutchtheplasticbasinintowhichheisvomitingandgesturinghellowiththeotherh